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A repetitive sequence specific toMycobacterium tuberculosis was isolated from a lgt11 library of
M. tuberculosis by DNA–DNA hybridization using genomic DNA of M. tuberculosis as probe
followed by subtractive hybridization with a cocktail of other mycobacterial DNA. This led to
identification of CD192, a 1291 bp fragment of M. tuberculosis containing repetitive sequences,
which produced positive hybridization signals withM. tuberculosis DNA within 30 min. Nucleotide
sequencing revealed the presence of several direct and inverted repeats within the 1291 bp
fragment that belonged to a PPE family gene (Rv0355) of M. tuberculosis. The use of CD192 as
a DNA probe for the identification of M. tuberculosis in culture and clinical samples was
investigated. The 1291 bp sequence was present in M. tuberculosis, Mycobacterium bovis and
M. bovis BCG, but was not present in many of the other mycobacterial strains tested, including
M. tuberculosis H37Ra. More than 300 clinical isolates of M. tuberculosis were probed with
CD192, and the presence of the 1291 bp sequence was observed in all the clinical strains,
including those lacking IS6110. The sequence displayed RFLP among the clinical isolates. A PCR
assay was developed which detected M. tuberculosis with 100% specificity from specimens of
sputum, cerebrospinal fluid and pleural effusion from clinically diagnosed cases of tuberculosis.
INTRODUCTION
One-third of the world’s population is estimated to be
infected with Mycobacterium tuberculosis. Hence, the identi-
fication of infected individuals comes as a first priority in
strategies for tuberculosis control. The culture of myco-
bacteria from clinical samples is considered to be the most
reliable technique and provides for definitive diagnosis of
tuberculosis. Although 100 % specific, it takes 6–8 weeks,
owing to the slow growth of the organisms and the need for
further biochemical testing (Heifets & Good, 1994). On the
other hand, nucleic acid probes coupled with amplification
allow rapid and specific identification of M. tuberculosis
in clinical samples (Pfyfer et al., 1996). Some of the probes
include insertion elements (IS6110, IS1081), genes for
immunodominant antigens (38 kDa, 85 protein complex,
30/32 kDa, MPB64) and ribosomal sequences (16S and 23S
rRNA) (Eisenach, 1999). These DNA probes are genus and
species specific and utilize a wide array of sequences from
a single-copy sequence to repetitive DNA elements. The
repetitive DNA elements offer the advantage of sensitivity,
and hence are ideal as diagnostic markers for strains.
Several repetitive DNA elements/sequences have been
reported in M. tuberculosis, such as IS6110, the direct
repeat (DR) cluster, IS1081, major polymorphic tandem
repeats (MPTRs), polymorphic GC-rich repetitive sequences
(PGRSs) and IS-like elements (Poulet & Cole, 1995). IS6110
is typically present in multiple copies in M. tuberculosis and
its species specificity, stability and RFLP make it a reliable
diagnostic and epidemiological tool to fingerprint M. tuber-
culosis strains (Eisenach et al., 1990; Kolk et al., 1992).
However, the discovery of several M. tuberculosis strains
with one or no copy of IS6110 (Sahadevan et al., 1995; Van
Soolingen et al., 1993) has shown that the repertoire of M.
tuberculosis strains present all over the world may not be
identified using a single repetitive element or probe. The
Abbreviations: ATT, antitubercular treatment; CSF, cerebrospinal fluid;
DR, direct repeat; IAC, internal amplification control; MPTR, major
polymorphic tandem repeat; NPV, negative predictive value; PGRS,
polymorphic GC-rich repetitive sequence; PPV, positive predictive value;
TBM, tuberculous meningitis.
The GenBank/EMBL/DDBJ accession number for the CD192
sequence of M. tuberculosis is 810514.
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search for novel DNA probes for M. tuberculosis remains a
constant requirement.
The present investigation describes the identification of a
repetitive sequence belonging to a PPE family gene of
M. tuberculosis and its use in the molecular diagnosis of
tuberculosis. The repetitive sequence was found useful in the
identification of M. tuberculosis from culture and from
clinical specimens of sputum, cerebrospinal fluid (CSF) and
pleural effusion.
METHODS
Bacterial strains and clinical specimens. All mycobacterial and
non-mycobacterial strains were obtained from the American Type
Culture Collection and the Central JALMA Institute for Leprosy,
Agra, India. Confirmed clinical isolates of M. tuberculosis were
obtained from the All India Institute of Medical Sciences, New Delhi,
the Postgraduate Institute of Medical Education and Research,
Chandigarh, and the King George Medical College, Lucknow. Four
clinical isolates of M. tuberculosis lacking IS6110 were obtained
from the Tuberculosis Research Centre, Chennai. Clinical specimens
(sputum, CSF and pleural effusion) were obtained from the King
George Medical College, the Command Hospital and the Tuber-
culosis Hospital, all in Lucknow, and from the Ganesh Shanker
Vidyarthi Medical College, Kanpur. Each specimen was streaked for
culture on LJ slants and grown at 37 uC for isolation of DNA. To
isolate DNA, the clinical materials were transferred into microcentri-
fuge tubes and incubated for 10 min at 80 uC to inactivate mycobac-
teria. Respiratory specimens, including sputum and pleural fluid,
were digested and decontaminated by N-acetyl-L-cysteine (NALC)/
4 % NaOH and concentrated by centrifugation at 3000 g for 15 min.
The sediments were resuspended in 50 ml phosphate buffer and
recentrifuged at 3000 g for 15 min (Kent & Kubica, 1985). The CSF
specimens were directly suspended in 50 ml phosphate buffer and
centrifuged as described above. Part of the sample was streaked for
culture on LJ slant and the rest of the sample was used for DNA
extraction. The identification of M. tuberculosis and other non-
tubercular mycobacteria was done by biochemical tests (Koneman
et al., 1997) and 16S rDNA sequencing (Kirschner et al., 1993).
Extraction of genomic DNA from culture and clinical sam-
ples. DNA from mycobacterial and non-mycobacterial strains was
isolated by the method of Marmur (1961), with slight modification
for mycobacterial DNA as described by Connell & Ollar (1999).
DNA from mycobacteria in clinical samples was isolated by the
method described by Miyazaki et al. (1993).
DIG probe labelling and detection. Genomic DNA was passaged
through a 25 gauge needle 8–10 times to shear DNA. Sheared DNA
was denatured in a boiling-water bath for 10 min at 95 uC followed
by chilling in ice. Denatured DNA was labelled by the non-radioactive
DIG DNA labelling and detection system (Boehringer Mannheim).
The reaction was incubated at 37 uC for 20 h. Hybridized probes
were immunodetected with anti-DIG–alkaline phosphatase and then
visualized as blue spots with nitroblue tetrazolium (NBT) and 5-
bromo-4-chloro-3-indolyl phosphate (BCIP) substrates. Hybridiza-
tion protocols described by Sambrook et al. (1989) were used.
Construction of genomic library and screening. A recombinant
expression library of M. tuberculosis H37Rv DNA was constructed in
the lgt11 vector, essentially as described by Young et al. (1985). All
DNA manipulations were carried out by standard protocols
(Sambrook et al., 1989). Briefly, genomic DNA was isolated from
M. tuberculosis H37Rv, sheared to a mean length of 5 kb with serial
passage through a 25 gauge needle, and treated with EcoRI methylase
and S-adenosyl methionine to methylate the EcoRI sites. The DNA
ends were then made flush with T4 DNA polymerase, and the DNA
was purified. EcoRI linkers were added to the flush ends of the geno-
mic DNA, and EcoRI sites were generated by digestion with EcoRI
restriction enzyme. The EcoRI fragments thus generated were ligated
in a small volume with EcoRI-digested dephosphorylated lgt11 DNA,
and the library was packaged and amplified on Escherichia coli
Y1088 at 42 uC, as described earlier (Young et al., 1985). The library
had a titre of 161010 p.f.u. ml21 and contained approximately 60 %
recombinants with a mean size of 4 kb.
The genomic library thus constructed was screened in two steps to
select out M. tuberculosis-specific DNA sequences. The library was
arrayed on a lawn of E. coli Y1088. The phage plaques were blotted onto
a nitrocellulose membrane and probed first with a mixture of DIG-
labelled genomic DNA of a clinical isolate of M. tuberculosis and
the H37Rv strain. The plaques that produced hybridization signals
intensely and rapidly within 30 min were picked and rescreened three
times using the same genomic DNA probe. Finally, after tertiary
screening, the plaques producing positive hybridization signals within
30 min were selected and subjected to subtractive screening in which
the selected plaques were screened with a cocktail of mycobacterial
DNA other than that of M. tuberculosis. This cocktail consisted of
DIG-labelled genomic DNA of Mycobacterium avium-intracellulare,
Mycobacterium fortuitum, Mycobacterium chelonae, Mycobacterium
smegmatis and Mycobacterium phlei, mixed in equal concentration.
After subtractive screening, the plaques hybridizing to M. tuberculosis
but not to the cocktail of mycobacteria were chosen for further
analysis.
PCR assay. The primers CD1 (59-tgttgccgccgaaggtcatta-39) and
CD2 (59-gcagtggaaacatcggagtat-39) were designed from the 1291 bp
CD192 fragment (GenBank accession no. 810514) using DNASTAR
and OMIGA softwares. CD1 and CD2 primers amplified a 777 bp
fragment. The PCR was performed in a 50 ml reaction volume
containing 15 mM MgCl2, 5 ml 106 PCR buffer (Promega; contain-
ing 100 mM Tris/HCl, pH 9?0 (25 uC), 500 mM KCl, 1 % Triton
X-100), 25 pmol each primer, 200 mM each deoxynucleotide tri-
phosphate, and 1?5 U Taq DNA polymerase (Promega). The tem-
perature regimen consisted of a denaturation cycle of 94 uC for
5 min followed by 96 uC for 1 min, 60 uC for 1 min and 72 uC for
1 min, for 30 cycles. An elongation step of 72 uC for 5 min ended
the PCR. The amplified product was electrophoresed on a 1?2 %
agarose gel in 16 Tris/borate/EDTA (TBE) running buffer, stained
in ethidium bromide and photographed under UV light. The pri-
mers T4 (59-cctgcgagcgtaggcgtcgg-39) and T5 (59-ctcgtccagcgccgct-
tcgg-39) were used for the detection of IS6110, which amplified a
123 bp product (Eisenach et al., 1993). The PCR produtcs were pur-
ified from the gel by a gel extraction kit (Qiagen) and the nucleotide
sequence was determined by automated sequencing on an ABI
PRISM 310 Genetic analyser (Perkin Elmer Applied Biosystems).
The sequence analysis was done using the DNASTAR program.
Southern hybridization. For Southern hybridization, the DNA
was digested with appropriate restriction enzymes and electrophor-
esed through an agarose gel. After the electrophoresis was complete,
the gel was stained with ethidium bromide and photographed. The
DNA from the agarose gel was transferred onto a nitrocellulose
membrane by the capillary transfer method after denaturation and
neutralization of DNA within the agarose gel. After the transfer, the
membrane was air-dried and baked at 80 uC under vacuum for 2 h.
The Southern blot after prehybridization at 42 uC for 2–3 h was
hybridized with DIG-labelled probe at 42 uC for 8–16 h with contin-
uous shaking, followed by detection. Hybridization conditions were
essentially as described by Sambrook et al. (1989). DIG labelling and
detection were done as described in the manufacturer’s protocol
(Boehringer Mannheim).
1072 Journal of Medical Microbiology 55
R. Srivastava and others
RFLP analysis. The genomic DNA from clinical isolates of M.
tuberculosis and non-tubercular mycobacteria was digested with the
StuI restriction enzyme. The restricted DNA fragments were electro-
phoresed through an agarose gel (0?8 %, 0?56 TBE buffer at
~1 V cm21). The DNA in the gel was denatured, and after neutrali-
zation was transferred onto a nitrocellulose membrane and hybri-
dized with denatured DIG-labelled 1291 bp fragment.
Calculation of sensitivity and specificity. The sensitivity of the
test was calculated as [TP/(TP+FN)]6100 %, the specificity was
calculated as [TN/(TN+FP)]6100 %; the positive predictive value
(PPV) was calculated as [TP/(TP+FP)]6100 %, and the negative
predictive value (NPV) was calculated as [TN/(TN+FN)]6100 %,
where TP is true positive, FN is false negative, TN is true negative
and FP is false positive.
RESULTS AND DISCUSSION
Screening of the lgt11 M. tuberculosis library
with genomic DNA of M. tuberculosis as probe
The genomic l expression library was plated to ~66103
p.f.u. per plate on E. coli Y1088. Approximately 60 000
recombinant plaques were screened, which represented the
whole genomic library of M. tuberculosis. Fourteen plaques
were selected as rapidly hybridizing clones after three
successive screenings with DIG-labelled denatured chromo-
somal DNA of M. tuberculosis as probe. These 14 plaques
produced hybridization signals within 30 min of detection.
The clones were then subjected to subtractive screening with
denatured chromosomal DNA from mycobacterial strains
other than M. tuberculosis by DNA hybridization. This
resulted in the elimination of six and the selection of eight
recombinant plaques which hybridized with M. tuberculosis
but not with denatured genomic DNA from M. avium-
intracellulare, M. fortuitum, M. chelonae, M. smegmatis and
M. phlei.
All eight clones contained inserts which were of different
sizes. One of the clones, referred to as C8, produced hybri-
dization signals within 10 min of detection. C8 contained an
insert of 4?2 kb. The rapid-signal-producing sequences were
mapped within a 1291 bp StuI–StuI fragment within the
4?2 kb insert (Srivastava et al., 2000). The 1291 bp fragment
was designated CD192.
Hybridization of CD192 with different
mycobacterial strains and other pathogens
The genomic DNA from different mycobacteria and other
pathogens was cleaved with the restriction enzyme StuI,
blotted onto nitrocellulose paper and hybridized with
DIG-labelled CD192 by Southern as well as dot-blot hybri-
dization. CD192 did not hybridize to DNA of different
mycobacterial and non-mycobacterial strains, which included
M. smegmatis, M. phlei, M. fortuitum, M. chelonae, Myco-
bacterium flavescens, Mycobacterium triviale, Mycobacterium
duvali, Mycobacterium marinum, Mycobacterium gordonae,
Mycobacterium kansasii, Mycobacterium avium, Mycobac-
terium intracellulare, Mycobacterium scrofulaceum, Myco-
bacterium xenopi, Mycobacterium aurum, Mycobacterium
microti and Mycobacterium szulgai. Similarly, no hybridiza-
tion was detected with Salmonella typhimurium, Staphylo-
coccus aureus, Proteus vulgaris, Pseudomonas aeruginosa,
Klebsiella pneumoniae, Enterobacter alginii, Vibrio cholerae,
Bacillus subtilis, E. coli, salmon sperm DNA and human
placental DNA.
Presence of CD192 in clinical isolates of
M. tuberculosis
Mycobacterial cultures were raised from clinical samples
and 366 cultures were obtained. Among these, 300 were
identified as M. tuberculosis, while the rest were M. flavescens
(n=28), M. fortuitum (n=22), M. chelonae (n=8), M.
triviale (n=6) and M. kansasii (n=2). Genomic DNA from
each isolate was digested with the restriction enzyme StuI,
blotted onto a nitrocellulose membrane and hybridized
with DIG-labelled CD192 probe DNA. Upon hybridization,
the probe detected only M. tuberculosis and no other myco-
bacteria. Essentially, all clinical M. tuberculosis isolates
consistently displayed three bands; however, in 30 % of
isolates, additional minor bands were obtained (Fig. 1).
RFLP of M. tuberculosis clinical strains before and after
prolonged passage in animals (mice) revealed identical
patterns, suggesting that the element was quite stable in vivo.
The 300 clinical isolates of M. tuberculosis were also analysed
for the presence of IS6110 by PCR amplification of a 123 bp
fragment (Eisenach et al., 1993). Out of 300 isolates, 32 were
devoid of IS6110 but contained CD192, as demonstrated by
hybridization and later confirmed by PCR (data not shown).
Nucleotide sequence of the CD192 DNA
fragment
The nucleotide sequence of CD192 was determined by the
dideoxy chain-termination sequencing technique for both
strands of CD192 (Biggins et al., 1983). The sequence has
Fig. 1. RFLP analysis. The genomic DNA from M. tuberculosis
H37Rv and clinical isolates of M. tuberculosis was isolated,
digested with the restriction enzyme StuI and electrophoresed
in a 0?8% agarose gel (16 Tris/acetate/EDTA buffer). The frag-
ments were electroblotted onto a nitrocellulose membrane and
probed with DIG-labelled CD192 probe. Lane 2, M. tuberculosis
H37Rv; lanes 1, 3–13, clinical isolates of M. tuberculosis.
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been submitted to GenBank with accession number 810514.
Computer-aided analysis of the nucleotide sequence and
deduced protein sequence was performed using databases
and programs provided by the National Institutes of Health
(http://www.ncbi.nlm.nih.gov/BLAST/BLAST), as well as
the programs of Chou & Fasman (1978) and Hopp & Woods
(1981). The homology search of the CD192 sequence
revealed it to be part of the PPE gene Rv0355c (424778–
434677 bp) on the M. tuberculosis genome. However, a
similar stretch on the M. tuberculosis genome is of 1286 bp
(Cole et al., 1998), whereas we have reported 1291 bp
(Srivastava et al., 2000). That the 1291 bp is part of Rv0355
was also confirmed by the sequencing of neighbouring
sequences present in the original 4?2 kb insert of the C8
clone. Rv0355c is 9900 bp long and encodes a 327?03 kDa
protein of no known function. This glycine/asparagine-rich
protein is a member of the M. tuberculosis PPE family, and
contains large numbers of DRs and MPTRs (Cole et al.,
1998). CD192 contained MPTRs (gccggtgttg or comple-
ment) characteristic of a PPE gene (Hermans et al., 1992;
Table 1).
Development of PCR-based assay
Different sets of primers were designed within the 1291 bp
sequence of CD192 using the DNASTAR and OMIGA software
packages and were subjected to PCR assay using target
DNA of M. tuberculosis, atypical mycobacteria and non-
mycobacterial species. The CD1 and CD2 primer pair was
selected, which amplified 777 bp of DNA from M. tuber-
culosis, and this was visualized by agarose gel electrophoresis
and DNA hybridization. A similar size fragment was ampli-
fied from Mycobacterium bovis and M. bovis BCG, but no
amplification was observed with other mycobacterial and
non-mycobacterial DNA, thus establishing the specificity
of the primers for M. tuberculosis. An internal control of
461 bp was developed which could be amplified by the
same CD1/CD2 primers for use as an internal amplification
control (IAC). CD192 has two SmaI sites at 227 and 407 bp,
and one NheI site at 541 bp. The removal of the NheI–SmaI
fragment resulted in the deletion of 316 bp from the
1291 bp fragment. When this deletion fragment served as
template, CD1 and CD2 primers amplified a fragment of
461 bp which was easily distinguishable from the 777 bp
fragment (Fig. 2). The deletion fragment could be seeded in
the sample or used separately to rule out the presence of
inhibitors in the sample in PCR reactions, which might
otherwise lead to false-negative results.
Evaluation of CD1/CD2 primers on clinical
samples
In this study, 200 clinical samples were selected to evaluate
the CD192 probe, and were derived from patients who were
clinically diagnosed cases of tuberculosis and responded to
antitubercular treatment (ATT). The study protocol was as
follows. Each collected sample was first streaked on LJ slants
for culture and the rest was stored for PCR. These patients
were immediately put on ATT. It is emphasized that the
probe CD192 was evaluated on those samples whose donors
were responding to ATT and that the samples were smear
negative. Therefore, according to the study design, evaluation
of the probe by PCR was carried out on clinically diagnosed
culture-negative and culture-positive tuberculosis cases.
Sputum samples
Two hundred and fifty sputum samples were examined,
which included samples from clinically diagnosed cases of
tuberculosis (n=105), and controls from other non-
mycobacterial respiratory diseases (n=80), mycobacteria
other than tuberculosis (MOTT) (n=20) and healthy
persons (n=45). Out of 105 samples, 65 were smear nega-
tive/culture positive and 40 were smear negative/culture
negative. All culture-positive samples were PCR positive,
and 30 out of 40 culture-negative samples were PCR
Table 1. Characteristics of DRs in the 1291 bp StuI–StuI DNA fragment
The US patent no. of the 1291 bp fragment is 6,114,514.
Serial
no.
Length
(bp)
Sequence Position (bp)
1 26 CCG ATG TTG TTG TTG
CCG GTG TTG GC
583, 613
2 10 TGA AGA AGC C 200, 1010, 1256
3 10 GCC CGT GTT G 312, 327, 357
4 10 TTG AGG ATG C 349, 379
5 9 CCG GTG TTG 208, 268, 298, 598
6 9 CCG ATG TTG 583, 613, 703, 733, 907
7 9 GTT GAA GTC 153, 333, 648, 864
8 9 GAA GAA GCC 201, 1011, 1161, 1257
9 9 GTT GCC GGT 264, 513, 594, 624
10 9 GCC GAC GTT 447, 672, 687, 807
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positive. All controls were negative by PCR (Table 2).
Hence, sensitivity and specificity for PCR were found to be
90?4 and 100 %, respectively. In a study reported earlier, the
probe CD192 was evaluated with CD1 and CD2 primers on
sputum samples, and 81 % sensitivity and 100 % specificity
for PCR was reported (Prasad et al., 2001).
Tuberculous meningitis (TBM)
One hundred and five CSF specimens were taken from 50
clinically diagnosed cases of TBM, and as a control, from 55
cases of non-tuberculous central nervous system (CNS)
disease, including viral encephalitis and pyogenic meningi-
tis. Patients with suspected TBM were those with fever and
stiff neck for longer than 2 weeks. All CSF specimens from
these patients had elevated leukocyte counts, polymorpho-
nuclear pleocytosis, an elevated protein concentration
(>60 mg dl21l) and CSF glucose concentration less than
60 % of the amount of glucose in the serum (Priyadarshi,
1999). The CSF samples were analysed for detection of
M. tuberculosis DNA by PCR using CD1 and CD2 primers.
A 777 bp fragment was amplified in 35 out of 50 CSF
specimens from clinically diagnosed TBM cases. Out of these
35, five were positive by culture. All controls were PCR
negative. Thus, the sensitivity of the probe for detection of
M. tuberculosis in CSF was 70 %, with 100 % specificity
(Table 2).
Pleural fluid specimens
The study was conducted on 45 cases of pleural effusion and
70 control subjects. Patients with pleural effusion presented
fever, chest pain, dry cough and dyspnoea, with pleural fluid
showing lymphocytosis, and the erythrocyte sedimentation
rate (ESR) was raised. Test groups included clinically diag-
nosed cases of tuberculous pleural effusion (n=45); the age
of patients varied between 12 and 71 years. Of 45 cases, 11
were culture positive and 34 PCR positive. All culture-
positive specimens were PCR positive. In the control group
of patients (n=70), none was culture or PCR positive. Thus
the sensitivity of PCR was 77?7 %, with 100 % specificity
(Table 2). In another isolated study, 22 specimens of pleural
fluid were examined, out of which 15 were clinically
suspected cases of pleural effusion and seven were of non-
tuberculous aetiology (control). All 15 samples were culture
negative, while 10 were PCR positive. In the control group
(n=7), two were diagnosed cases of malignancy, being cases
of adenocarcinoma confirmed by pleural fluid cytology; the
Fig. 2. PCR amplification of M. tuberculosis and IAC DNA by
CD1 and CD2 primers. Lane 1, 100 bp ladder (MBI Fermenta);
lane 2, 777 bp fragment amplified from M. tuberculosis; lane 3,
461 bp fragment of IAC DNA; lane 4, amplification of 777 and
461 bp fragments from sample containing both M. tuberculosis
and IAC DNA.
Table 2. Detection of M. tuberculosis in clinical specimens
Test Tuberculosis samples* Control samples Sensitivity
(%)
Specificity
(%)
NPV
(%)
PPV
(%)
Positive Negative Positive Negative
Sputum
Culture 65 40 2 145 62?9 100 78?3 100
PCR 95 10 2 145 90?4 100 92?9 100
CSF
Culture 5 45 2 55 10?0 100 55?0 100
PCR 35 15 2 55 70?0 100 78?5 100
Pleural fluid
Culture 11 34 2 70 24?4 100 67?3 100
PCR 35 10 2 70 77?7 100 87?5 100
*Specimens from clinically diagnosed cases of tuberculosis; all responded to ATT.
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remaining five were cases of pyogenic pleural effusion. One
specimen of malignant pleural effusion gave a positive result
by PCR, which is difficult to explain because the patient died
shortly afterwards (Veerottam, 1999).
In this study, a new domain of repetitive sequence (CD192)
has been identified within a PPE gene (Rv0355), as defined
in the M. tuberculosis genome (Cole et al., 1998). Rv0355 is a
member of the PPE gene family, characterized by the
presence of the motif proline-proline-glutamic acid (PPE) at
positions 7 and 9 in a highly conserved N-terminal domain
of 180 amino acids followed by a variable C-terminal region.
The 68 members of the PPE family have been classified into
three subfamilies; one of these subfamilies contains MPTR
and PGRS sequences that are characterized by repeats of
the motif AsnXGlyXGlyXAsnXGly. CD192 belongs to this
family and contains several MPTRs (gccggtgttg), PGRSs
(ttgccgccg), and several DRs, including a 26 bp sequence
present in tandem copies separated by four bases. The
MPTRs and PGRSs, originally described as non-coding
repetitive sequences in the genome of M. tuberculosis
(Hermans et al., 1992; Poulet & Cole, 1995; Ross et al.,
1992), have been exploited as epidemiological tools to
differentiate M. tuberculosis strains (Braden et al., 1997;
Ross et al., 1992; Van Soolingen et al., 1993).
Pulmonary tuberculosis is the most common presentation
of tuberculosis, but it can affect any organ system, and
clinical specimens other than sputum are known for the
limited presence of bacilli. With the progression of disease,
the presence of M. tuberculosis, the aetiological agent of
tuberculosis, can be demonstrated microscopically in
sputum, but the presence of bacilli in other forms of
tuberculosis, such as TBM, pleural effusion or other extra-
pulmonary tuberculosis, is very difficult to detect because of
low numbers of bacilli. The situation is aggrevated by the
low culture positivity of these samples. The high prevalence
of infection in an otherwise clinically undiagnosed popula-
tion is also a very serious problem. In the management of
tuberculosis, an assay which is rapid, specific and can detect
few bacilli is very important. Therefore, sequence-specific
amplification by PCR becomes the method of choice. If the
target which is amplified or the probe which is used for
hybridization contains repetitive sequences, the probability
of adequate sensitivity is enhanced several-fold.
CD192 appears to fulfil these criteria. It contains repeti-
tive sequences that produce hybridization signals within
10–30 min and is specific to M. tuberculosis. To assay its
potential in diagnosis, a PCR assay was developed, and
primers were used to detect M. tuberculosis in pulmonary,
CSF and pleural-fluid specimens. The latter two contain
very few bacilli and are usually culture negative, and specific
diagnosis is urgently needed, because if untreated, the
disease follows a chronic course that causes significant
morbidity and mortality.
There are few DNA probes available for the detection of M.
tuberculosis. The commercially available PCR test for the
detection of M. tuberculosis complex marketed by Roche
Diagnostic Systems amplifies a region of the 16S rDNA
sequence that is genus specific and employs an M. tuber-
culosis complex-specific probe. The GenProbe amplified M.
tuberculosis Direct (MTD) test employs the transcription-
mediated amplification of 16S rRNA and is M. tuberculosis
complex specific (Jonas et al., 1993; Scarparo et al., 2000).
IS6110 has been used as a reliable, sensitive marker in the
diagnosis of tuberculosis due to its high copy number, but
has the limitation that it is not found in all M. tuberculosis
clinical isolates (Sahadevan et al., 1995). CD192 demon-
strated good sensitivity and specificity in sputum, CSF and
pleural effusion, and was present in M. tuberculosis strains
lacking IS6110. Thus, CD192 may be recommended for use
in the identification of M. tuberculosis. The results of this
investigation are based on long-term evaluation of pulmon-
ary (sputum) and extrapulmonary tuberculosis patients,
and reports good sensitivity and 100 % specificity with
pulmonary and extrapulmonary samples.
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